Stahl A, Joyal J-S, Chen J, et al. SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood. 2012;120(14):2925-2929.

In the Authorship section on page 2928 in the 4 October 2012 issue, the conflict-of-interest statement should read, “D.P. owns stock options in and serves as an unpaid scientific advisor for Tempest Therapeutics. The remaining authors declare no competing financial interests.”